Angiogenetic signaling through hypoxia: HMGB1: an angiogenetic switch molecule. - Wikidata - wikimedia - TriplyDB

Angiogenetic signaling through hypoxia: HMGB1: an angiogenetic switch molecule.

Angiogenetic signaling through hypoxia: HMGB1: an angiogenetic switch molecule.

http://www.wikidata.org/entity/Q38585899

about

High mobility group Box 1 inhibits human pulmonary artery endothelial cell migration via a Toll-like receptor 4- and interferon response factor 3-dependent mechanism(s)HMGB1: endogenous danger signaling The Toll of Vascular Insufficiency: Implications for the Management of Peripheral Arterial Disease Circulating HMGB1 and RAGE as Clinical Biomarkers in Malignant and Autoimmune Diseases The Role of HMGB1 Signaling Pathway in the Development and Progression of Hepatocellular Carcinoma: A Review High-mobility group box 1: an amplifier of stem and progenitor cell activity after stroke Decellularized matrix from tumorigenic human mesenchymal stem cells promotes neovascularization with galectin-1 dependent endothelial interaction HMGB1 attenuates cardiac remodelling in the failing heart via enhanced cardiac regeneration and miR-206-mediated inhibition of TIMP-3 Damage-associated molecular patterns in cancer: a double-edged sword Clinical Value of High Mobility Group Box 1 and the Receptor for Advanced Glycation End-products in Head and Neck Cancer: A Systematic Review Cellular Stress Response and Immune Signaling in Retinal Ischemia-Reperfusion Injury Alarmins: awaiting a clinical response High-mobility group box 1 and cancer.Co-expression of nuclear and cytoplasmic HMGB1 is inversely associated with infiltration of CD45RO+ T cells and prognosis in patients with stage IIIB colon cancer.Senescent cells as a source of inflammatory factors for tumor progression.High-mobility group box-1 protein promotes angiogenesis after peripheral ischemia in diabetic mice through a VEGF-dependent mechanism.The role of high mobility group box 1 in innate immunity.A simple method for establishing adherent ex vivo explant cultures from human eye pathologies for use in subsequent calcium imaging and inflammatory studies HMGB1 is associated with atherosclerotic plaque composition and burden in patients with stable coronary artery disease.HMGB1 and TLR4 mediate skeletal muscle recovery in a murine model of hindlimb ischemia.HMGB1 in health and disease.Implication of snail in metabolic stress-induced necrosis.Failure of anti tumor-derived endothelial cell immunotherapy depends on augmentation of tumor hypoxia.High mobility group box-1 and its clinical value in breast cancer.High-mobility group box-1 and biomarkers of inflammation in the vitreous from patients with proliferative diabetic retinopathy.Homeobox gene Dlx-2 is implicated in metabolic stress-induced necrosis.Morphological characterization of intra-articular HMGB1 expression during the course of collagen-induced arthritis.Stage-specific secretion of HMGB1 in cartilage regulates endochondral ossification.HMGB1 is a therapeutic target for sterile inflammation and infection.Astrocytic high-mobility group box 1 promotes endothelial progenitor cell-mediated neurovascular remodeling during stroke recovery.High-mobility group box-1 and endothelial cell angiogenic markers in the vitreous from patients with proliferative diabetic retinopathy LPS-Primed Release of HMGB-1 from Cortical Astrocytes is Modulated Through PI3K/AKT Pathway Expression of high mobility group box 1 protein predicts a poorer prognosis for patients with osteosarcoma.Early growth response 1 regulates glucose deprivation-induced necrosis.High-mobility group box 1 from reactive astrocytes enhances the accumulation of endothelial progenitor cells in damaged white matter.High mobility group box 1 promotes endothelial cell angiogenic behavior in vitro and improves muscle perfusion in vivo in response to ischemic injury.HMGB1: a signal of necrosis.Many faces of DAMPs in cancer therapy.HMGB1 induces human lung endothelial cell cytoskeletal rearrangement and barrier disruption Association between an elevated level of HMGB1 and non-small-cell lung cancer: a meta-analysis and literature review.

P2860

Q24303714-63A971CD-A099-4279-BBD5-D9316C892806 Q24645232-176A6EEA-648A-46C5-A5E9-3E025D77C364 Q26753079-8D1C2E1F-9B62-48E9-820D-0605CA1E0F9A Q26768480-E017505B-504A-4D34-8295-BD90EC62236A Q26782281-5BCF6591-3F37-4D39-97CD-55E7F1FE0A24 Q27008225-0BEA6984-8039-473D-9214-E2E5674906CF Q27333526-17DCD7AB-F588-4125-BC4D-1DDCD076F6AF Q27342035-BCED9890-13A5-4D4D-9FE8-13530D78057D Q28067434-A19CE682-8351-4C51-B6C4-EAD356A2FA37 Q28074543-76C40F84-A002-497E-8E37-9A67115D96EB Q28079203-574B7156-7FDA-4D68-8103-2DEF5BF71252 Q30523797-A721B98F-0D1C-49BF-ADA8-FB1E66882B43 Q33638306-C13FEF8D-761B-4BF5-87D5-FD6934BEBE6F Q33693936-7762A919-CC12-48CA-AD56-72630FE96A68 Q33833881-B9E10BC3-C133-4628-B584-F966577B8265 Q33869816-B008E6E6-BFF5-404D-B7E4-B768CF7A6508 Q33941549-27F2E78E-557D-4DEE-8A3A-594ED2A81B66 Q34207592-9B674296-7D94-4284-A914-5AF1F2026A1A Q34532933-9943EA02-B278-4DD0-B0B9-878E9553BA35 Q34588764-8597137E-CB35-415F-9296-CCC2F5526210 Q34622835-8E8FCE7E-344B-40AD-8095-D9769F7F8BF4 Q34713056-430E824B-98C2-421C-BB8E-6D3E827A581D Q34786452-474205AB-A57F-4966-830B-34FF5FB06B22 Q35101004-F28D2EF2-0356-4EAC-84F2-03384D273704 Q35108807-5C2E75A1-E444-4FE0-981D-68A97A1DFD0D Q35235227-0C99B1CE-F394-49C1-8631-DEB6C6B4B4E9 Q35869016-87ACDD03-047C-4CEA-9FB3-1ED93AEE68A7 Q35950201-CDBE2967-7F66-42AF-B7D8-4E25C43E7CE3 Q35953553-16A656EE-698E-4505-A583-3BA09B5D4A0F Q35982936-D9227FD5-B167-4610-85A5-6F5570E2CDD6 Q36340353-50B7E5CE-2D2F-494E-9DED-AA0E6CBEA615 Q36431384-16AF5131-1534-4D9D-9F93-303A4AF43A93 Q36502721-964A6FF6-7D24-4DDC-89DD-736792F23E2C Q36642750-0F9ABBFB-C377-42DE-AA16-EB968BDED3D1 Q36703858-985A0687-320E-407A-9902-91FC507D11E8 Q36706670-E6939E9B-212A-4FAC-9777-9D8DCF563594 Q36827934-BC649686-CB9D-4AC3-8A3E-8E290D6F48A4 Q36907117-CB9BB62F-E1B7-47E8-91D0-3BDBD3A2BDB5 Q36919024-37951D98-3309-471A-A7E2-F722D1465D8F Q37070689-BF2D358E-27B0-4516-AA8B-D559BAD35122

P2860

Angiogenetic signaling through hypoxia: HMGB1: an angiogenetic switch molecule.

http://www.wikidata.org/entity/Q38585899

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

2005年论文

@zh

2005年论文

@zh-cn

name

Angiogenetic signaling through hypoxia: HMGB1: an angiogenetic switch molecule.

@en

type

label

Angiogenetic signaling through hypoxia: HMGB1: an angiogenetic switch molecule.

@en

prefLabel

Angiogenetic signaling through hypoxia: HMGB1: an angiogenetic switch molecule.

@en

P1433

Q38585899-90D213E6-DD7A-488D-8CE4-33A237FA333E

P1476

Q38585899-96BB17E8-E8B9-4EF7-8434-C743090447DF

P2093

Q38585899-44ABCB0B-DE93-4F57-8C99-8D4BEA54B5B2

Q38585899-66149F35-0FE4-4638-AAD1-B1CC1E707916

Q38585899-7CD28D9D-EA09-4E61-9DF9-24FF0E9A890B

Q38585899-8913BED9-6FB6-45DD-91E1-12025EE9EB2C

Q38585899-A605D702-84C4-4778-A9BF-FBCD4A87C944

Q38585899-A9DA0D00-70C9-44E6-BA12-691EFC16F38D

Q38585899-CD81AEA4-8C2A-40D4-8BD8-C40D7C07B3AB

P2860

Q38585899-0DC53345-B307-463E-B312-D244A8A0C068

Q38585899-2189B1C4-FD49-442E-A7EF-9C9715D27F89

Q38585899-30FBA276-23C1-4CA9-8451-A752F8FC5E02

Q38585899-31BADE89-D455-4D28-B600-1E42A66B0565

Q38585899-36814BB2-492B-4155-A4A3-FC95C2879166

Q38585899-3777979B-6935-4452-849E-D44CDE847AE5

Q38585899-48E78BFA-67AE-4D4E-AA6A-89CE980D8F1C

Q38585899-587E496B-68B1-4C37-8B13-9702157DF0E2

Q38585899-606D0379-CE30-48C4-A5CD-F0F282464555

Q38585899-69E09018-5B7C-437E-A20B-3CFDACFD49FE

P304

Q38585899-56AC8804-A183-4B22-AEFE-DC547ACCFDF6

P31

Q38585899-D2446BB1-6C47-4083-A1E7-986175848452

P356

Q38585899-28DAAAE1-86B1-4068-A7B3-8AA2AA9C551D

P407

Q38585899-CF065293-D908-42CB-AD7F-5716B0963D72

P433

Q38585899-3B4821EB-35CD-4F9C-80D0-BB9BE8BDC985

P478

Q38585899-2D03DF2B-F7F1-4FE5-9549-68BD99D52555

P577

Q38585899-CD9081EE-7AB0-49CB-8019-C287DD940CA9

P698

Q38585899-AC719ACE-759C-4E1D-9D09-590E0D28AFDD

P921

Q38585899-EFA7E8F8-1090-414C-9D44-365D4041D3C7

P932

Q38585899-88B93E22-DE35-40AB-8045-6173CA7E5216

P356

S0002-9440(10)62344-9

P1433

The American Journal of Pathology

P1476

Angiogenetic signaling through hypoxia: HMGB1: an angiogenetic switch molecule.

@en

P2093

Britta Meyer

http://www.w3.org/2001/XMLSchema#string

Claudia Schlueter

http://www.w3.org/2001/XMLSchema#string

Holger Weber

http://www.w3.org/2001/XMLSchema#string

Jörn Bullerdiek

http://www.w3.org/2001/XMLSchema#string

Kerstin Röser

http://www.w3.org/2001/XMLSchema#string

Piere Rogalla

http://www.w3.org/2001/XMLSchema#string

Sven Hauke

http://www.w3.org/2001/XMLSchema#string

P2860

The nuclear protein HMGB1 is secreted by monocytes via a non-classical, vesicle-mediated secretory pathway

Release of chromatin protein HMGB1 by necrotic cells triggers inflammation

HMG-1 as a late mediator of endotoxin lethality in mice

HMGB1 as a DNA-binding cytokine

HMGB1, an architectural chromatin protein and extracellular signalling factor, has a spatially and temporally restricted expression pattern in mouse brain

The receptor for advanced glycation end products (RAGE) is a cellular binding site for amphoterin. Mediation of neurite outgrowth and co-expression of rage and amphoterin in the developing nervous system

The high mobility group (HMG) boxes of the nuclear protein HMG1 induce chemotaxis and cytoskeleton reorganization in rat smooth muscle cells

Hypoxia--a key regulatory factor in tumour growth

Regulation of angiogenesis by hypoxia: role of the HIF system

Tumorigenesis and the angiogenic switch

P304

1259-1263

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/S0002-9440(10)62344-9

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

166

http://www.w3.org/2001/XMLSchema#string

P577

2005-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15793304

http://www.w3.org/2001/XMLSchema#string

P921

P932

1602384

http://www.w3.org/2001/XMLSchema#string